Knight Therapeutics (TSE:GUD) Given Outperform Rating at Raymond James  Trent Times

Knight Therapeutics (TSE:GUD)’s stock had its “outperform” rating reissued by stock analysts at Raymond James in a research report issued on Thursday, July …